Impact of body mass index on estradiol depletion by aromatase inhibitors in postmenopausal women with early breast cancerGeorg Pfeiler, Peter Dubsky, Robert Königsberg et al.|British Journal of Cancer|2013Cited by 64
Pathological Complete Response to Neoadjuvant Trastuzumab Is Dependent on HER2/CEP17 Ratio in HER2-Amplified Early Breast CancerChristian F. Singer, Michael Gnant, Martin Filipits et al.|Clinical Cancer Research|2017Cited by 61
Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34)Christian F. Singer, Michael Gnant, Vesna Bjelic‐Radisic et al.|European Journal of Cancer|2020Cited by 52
Continued Endocrine Therapy Is Associated with Improved Survival in Patients with Breast Cancer Brain MetastasesElisabeth Bergen, Rupert Bartsch, Karin Dieckmann et al.|Clinical Cancer Research|2019Cited by 46
The multigene signature MammaPrint impacts on multidisciplinary team decisions in ER+, HER2− early breast cancerRuth Exner, Peter Dubsky, Zsuzsanna Bagó-Horváth et al.|British Journal of Cancer|2014Cited by 38